0001104659-24-011200.txt : 20240206
0001104659-24-011200.hdr.sgml : 20240206
20240206183558
ACCESSION NUMBER: 0001104659-24-011200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240203
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strassburger Philip C.
CENTRAL INDEX KEY: 0001825592
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36554
FILM NUMBER: 24601565
MAIL ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OCULAR THERAPEUTIX, INC
CENTRAL INDEX KEY: 0001393434
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-895-3235
MAIL ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: I-THERAPEUTIX INC
DATE OF NAME CHANGE: 20070315
4
1
tm245295-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-03
0
0001393434
OCULAR THERAPEUTIX, INC
OCUL
0001825592
Strassburger Philip C.
C/O OCULAR THERAPEUTIX, INC.
24 CROSBY DRIVE
BEDFORD
MA
01730
0
1
0
0
General Counsel
0
Common Stock
2024-02-03
4
A
0
58304
0
A
167522
D
Common Stock
2024-02-05
4
S
0
6029
4.86
A
161493
D
Stock Option (Right to Buy)
5.18
2024-02-03
4
A
0
175000
0
A
2034-02-02
Common Stock
175000
175000
D
On February 3, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation 's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2024. The sales do not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.94, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
/s/ Donald Notman, Attorney-in-Fact for Philip C. Strassburger
2024-02-06